Molecular epidemiology: recent advances and future directions

被引:143
作者
Perera, FP [1 ]
Weinstein, IB
机构
[1] Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Environm Hlth Sci, New York, NY 10032 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
关键词
D O I
10.1093/carcin/21.3.517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In 1982 me proposed the concept and a framework for implementing molecular cancer epidemiology. Here, we review progress during the past 17 years in validating and applying this approach to cancer prevention. There have been major advances, notably in the understanding of environment-susceptibility interactions in human cancer. However, a review of major findings to date reveals several urgent research needs to keep pace with the rapid evolution in knowledge of mechanisms in carcinogenesis. Although much valuable progress continues to be made in the study of carcinogens that cause direct DNA damage and are mutagenic, exogenous and endogenous carcinogens can also act by altering gene expression, cell proliferation and differentiation. The mechanisms include aberrant DNA methylation, oxidative damage, effects on metabolism of nitrogen oxide and nitrites, activation of receptors and transcription factors, cyclins and other cell cycle proteins. Sensitive, validated biomarkers are needed to detect these mechanisms in small numbers of cells, tissues or fluids. There is also increasing recognition that individual risk from carcinogen exposure varies as a function of both inherited and acquired factors. Recent advances in genomics, microassay technologies and informatics hold promise for rapid identification of polymorphic variants or changes in expression of genes influencing both response and susceptibility to carcinogens. Another emerging area of molecular epidemiology concerns the role of nutrition and specific dietary factors (including studies on antioxidants, energy metabolism, insulin and various growth factors) and the modulating effect of genetic polymorphisms. Finally, molecular epidemiology has enormous potential in cancer prevention through the early identification of 'at risk' populations and the rapid assessment of intervention efficacy. Its success in fully reaching this potential will depend on the application of validated biomarkers, with adherence to sound epidemiologic and ethical principles.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 87 条
[61]   THE IMPACT OF GLUTATHIONE-S-TRANSFERASE M1 AND CYTOCHROME-P450 1A1 GENOTYPES ON WHITE-BLOOD-CELL POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCT LEVELS IN HUMANS [J].
ROTHMAN, N ;
SHIELDS, PG ;
POIRIER, MC ;
HARRINGTON, AM ;
FORD, DP ;
STRICKLAND, PT .
MOLECULAR CARCINOGENESIS, 1995, 14 (01) :63-68
[62]  
RUDIGER HW, 1989, CANCER RES, V49, P5623
[63]  
SANTELLA RM, 1990, BASIC LIFE SCI, V53, P33
[64]  
Schulte P A, 1997, IARC Sci Publ, P313
[65]   ETHICAL CONSIDERATIONS, CONFIDENTIALITY ISSUES, RIGHTS OF HUMAN-SUBJECTS, AND USES OF MONITORING DATA IN RESEARCH AND REGULATION [J].
SCHULTE, PA ;
SWEENEY, MH .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :69-74
[66]   EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER [J].
SCHWEIKL, H ;
TAYLOR, JA ;
KITAREEWAN, S ;
LINKO, P ;
NAGORNEY, D ;
GOLDSTEIN, JA .
PHARMACOGENETICS, 1993, 3 (05) :239-249
[67]   ISOENZYME(S) OF GLUTATHIONE TRANSFERASE (CLASS-MU) AS A MARKER FOR THE SUSCEPTIBILITY TO LUNG-CANCER - A FOLLOW-UP-STUDY [J].
SEIDEGARD, J ;
PERO, RW ;
MARKOWITZ, MM ;
ROUSH, G ;
MILLER, DG ;
BEATTIE, EJ .
CARCINOGENESIS, 1990, 11 (01) :33-36
[68]   PROTEIN ADDUCTS IN THE MOLECULAR DOSIMETRY OF CHEMICAL CARCINOGENS [J].
SKIPPER, PL ;
TANNENBAUM, SR .
CARCINOGENESIS, 1990, 11 (04) :507-518
[69]   Chemoprevention of cancer [J].
Sporn, MB ;
Suh, N .
CARCINOGENESIS, 2000, 21 (03) :525-530
[70]   UBIQUITOUS BINDING OF BENZO[A]PYRENE METABOLITES TO DNA AND PROTEIN IN TISSUES OF THE MOUSE AND RABBIT [J].
STOWERS, SJ ;
ANDERSON, MW .
CHEMICO-BIOLOGICAL INTERACTIONS, 1984, 51 (02) :151-166